Eric Warren Esperion Therapeutics, Inc. (ESPR) insider trading activity
Eric Warren is Chief Commercial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 370,218 shares of ESPR, which is worth approximately $551,624. The most recent transaction as insider was on Aug 31, 2022, when has been sold 1,000 shares (Common Stock) at a price of $7.46 per share, resulting in proceeds of $7,460. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
370K
0%
3M change
123.73%
12M change
Total Value Held
$551,624
Eric Warren Transaction History
EW
Eric Warren
Chief Commercial Officer
Ann Arbor, MI